# Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery

Study · id `cardio:ct-nct01728441` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01728441](<https://clinicaltrials.gov/study/NCT01728441>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01728441

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

## Technical summary

Registry record NCT01728441. Randomized; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT01728441, source copy `cardio:ctgov-nct01728441-2014-05-20`, retrieved 2026-10-31)
- Start date: 2012-10 (registry gives no type) (ClinicalTrials.gov record NCT01728441, source copy `cardio:ctgov-nct01728441-2014-05-20`, retrieved 2026-10-31)
- Primary completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01728441, source copy `cardio:ctgov-nct01728441-2014-05-20`, retrieved 2026-10-31)
- Completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01728441, source copy `cardio:ctgov-nct01728441-2014-05-20`, retrieved 2026-10-31)
- Countries: Belgium; Germany (ClinicalTrials.gov record NCT01728441, source copy `cardio:ctgov-nct01728441-2014-05-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01728441-2014-05-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery
- Condition: Peripheral Artery Disease
- Intervention (Device): Paclitaxel Eluting Stent
- Intervention (Device): Paclitaxel Eluting Balloon
- Lead sponsor: Provascular GmbH
- Lead sponsor class: OTHER
- Collaborator: William Cook Europe
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease (`cardio:pubmed-30765033`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 46ef668fd15442dbb006719cfb4a5ee23901e0dab75867346416146066016756
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
